UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Phase 2 trial of dovitinib in patients with progressive FGFR3 -mutated or FGFR3 wild-type advanced urothelial carcinoma

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3145-3152

2014

Link zum Volltext

Verfügbarkeit prüfen

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

Clinical cancer research, 2017-05, Vol.23 (10), p.2451-2459

2017

Link zum Volltext

Verfügbarkeit prüfen

What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?

International Brazilian journal of urology, 2014-12, Vol.40 (6), p.772-780

2014

Link zum Volltext

Verfügbarkeit prüfen

Germline alterations among Hispanic men with prostate cancer

Prostate cancer and prostatic diseases, 2022-09, Vol.25 (3), p.561-567

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Germline alterations among Hispanic men with prostate cancer

Prostate cancer and prostatic diseases, 2022-09, Vol.25 (3), p.599-599

2022

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis

Clinical genitourinary cancer, 2019-06, Vol.17 (3), p.e505-e512

2019

Link zum Volltext

Verfügbarkeit prüfen

844 COMPARATIVE ANALYSIS OF COMPLICATIONS IN OPEN VERSUS MINIMALLY INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION IN A NATIONAL COHORT

The Journal of urology, 2012-04, Vol.187 (4), p.e344-e344

2012

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.110-110

2020

Link zum Volltext

Verfügbarkeit prüfen

The prognostic significance of homologous recombination repair pathway alterations in metastatic hormone-sensitive prostate cancer

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.150-150

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of germline alterations and testing patterns in Hispanic men with prostate cancer

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.18-18

2021

Link zum Volltext

Verfügbarkeit prüfen

Palliative irradiation of the spleen

American journal of clinical oncology, 2003-04, Vol.26 (2), p.178-183

2003

Link zum Volltext

Verfügbarkeit prüfen

Rate of occult metastases in patients (pts) with biochemically-recurrent prostate cancer (BRPC) from a phase 2 trial of sipuleucel-T and androgen deprivation therapy (STAND)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16516-e16516

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up from STAMP, a phase II trial, evaluating sipuleucel-T and concurrent (CON) vs sequential (SEQ) abiraterone acetate + prednisone in metastatic castration-resistant prostate cancer patients (pts)

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.190-190

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract A55: Phase 1 results of emibetuzumab (LY2875358), a bivalent MET antibody, in patients with advanced castration-resistant prostate cancer, and MET positive renal cell carcinoma, non-small cell lung cancer, and hepatocellular carcinoma

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.A55-A55

2015

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) plus prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5047-5047

2013

Link zum Volltext

Verfügbarkeit prüfen

Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.255-255

2013

Link zum Volltext

Verfügbarkeit prüfen

A QTc study of cabazitaxel in patients with advanced solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15115-e15115

2012

Link zum Volltext

Verfügbarkeit prüfen

A QTc study of cabazitaxel in patients with advanced solid tumors

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.257-257

2012

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte Colony-Stimulating Factor Versus Placebo in Addition to Penicillin G in a Randomized Blinded Study of Gram-Negative Pneumonia Sepsis: Analysis of Survival and Multisystem Organ Failure

Blood, 1995-08, Vol.86 (4), p.1301-1309

1995

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic Markers and BCL-1 Gene Rearrangements in B-Cell Chronic Lymphocytic Leukemia: A Cancer and Leukemia Group B Study

Blood, 1993-08, Vol.82 (4), p.1239-1246

1993

Link zum Volltext

Verfügbarkeit prüfen

Palliative Irradiation of the Spleen

American journal of clinical oncology, 2003-04, Vol.26 (2), p.178-183

2003

Link zum Volltext

Verfügbarkeit prüfen

Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features : A Phase II Cancer and Leukemia Group B study (9051)

Cancer, 1999-10, Vol.86 (8), p.1590-1595

1999

Link zum Volltext

Verfügbarkeit prüfen

Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized hodgkin disease and unfavorable prognostic features

Cancer, 1999-10, Vol.86 (8), p.1590-1595

1999

Link zum Volltext

Verfügbarkeit prüfen

Clinical manifestations of essential thrombocythemia in young adults

American journal of hematology, 1990-01, Vol.33 (1), p.27-31

1990

Link zum Volltext

Verfügbarkeit prüfen

A Specific Assay for Anti-HLA Antibodies: Application to Platelet Donor Selection

Blood, 1987-11, Vol.70 (5), p.1495-1499

1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 2 trial of dovitinib in patients with progressive FGFR3 -mutated or FGFR3 wild-type advanced urothelial carcinoma

Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial

What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?

Germline alterations among Hispanic men with prostate cancer

Correction: Germline alterations among Hispanic men with prostate cancer

Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis

844 COMPARATIVE ANALYSIS OF COMPLICATIONS IN OPEN VERSUS MINIMALLY INVASIVE RETROPERITONEAL LYMPH NODE DISSECTION IN A NATIONAL COHORT

Analysis of the prognostic significance of circulating tumor DNA (ctDNA) in metastatic castrate-resistant prostate cancer (mCRPC)

The prognostic significance of homologous recombination repair pathway alterations in metastatic hormone-sensitive prostate cancer

Analysis of germline alterations and testing patterns in Hispanic men with prostate cancer

Palliative irradiation of the spleen

Rate of occult metastases in patients (pts) with biochemically-recurrent prostate cancer (BRPC) from a phase 2 trial of sipuleucel-T and androgen deprivation therapy (STAND)

Long-term follow-up from STAMP, a phase II trial, evaluating sipuleucel-T and concurrent (CON) vs sequential (SEQ) abiraterone acetate + prednisone in metastatic castration-resistant prostate cancer patients (pts)

Abstract A55: Phase 1 results of emibetuzumab (LY2875358), a bivalent MET antibody, in patients with advanced castration-resistant prostate cancer, and MET positive renal cell carcinoma, non-small cell lung cancer, and hepatocellular carcinoma

A randomized phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) plus prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC)

Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3

A QTc study of cabazitaxel in patients with advanced solid tumors

A QTc study of cabazitaxel in patients with advanced solid tumors

Granulocyte Colony-Stimulating Factor Versus Placebo in Addition to Penicillin G in a Randomized Blinded Study of Gram-Negative Pneumonia Sepsis: Analysis of Survival and Multisystem Organ Failure

Phenotypic Markers and BCL-1 Gene Rearrangements in B-Cell Chronic Lymphocytic Leukemia: A Cancer and Leukemia Group B Study

Palliative Irradiation of the Spleen

Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features : A Phase II Cancer and Leukemia Group B study (9051)

Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized hodgkin disease and unfavorable prognostic features

Clinical manifestations of essential thrombocythemia in young adults

A Specific Assay for Anti-HLA Antibodies: Application to Platelet Donor Selection

Suchergebnisse filtern